CrushSCI.com
57.5平均天数
52中位天数
34最短天数
92最长天数
7612025发文量

Paper Review Records

全部论文审稿周期

4 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

92 天

Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions of Aficamten in the Chinese Population

作者
Ziyang Wang; Xiaofei Wu; Ranran Jia; Hongyun Wang展开收起
作者单位
1. Clinical Pharmacology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China展开收起
官方全文证据 DOI 网页
66 天

Creatinine Clearance, Ceftazidime-Avibactam Exposure, and Clinical Outcomes in a Real-World TDM Cohort: A Retrospective Observational Study

作者
Bo Yang; Jianbiao Meng; Bei Zheng; Juan Wang; Nanmei Chen; Mingwan Zhang; Chuanwei Xin; Meiling Zhang; Yuexing Tu展开收起
作者单位
1. Department of Pharmacy, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2. Department of Critical Care Medicine, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 3. Department of Clinical Laboratory Science, Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China展开收起
官方全文证据 DOI 网页
34 天

Effect of Etomidate Induction on Intraoperative Hemodynamics, Postoperative Inflammation, and Recovery After Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study

作者
Jiazheng Qi; Zhiying Zheng; Yanrong Gu; Manyu Duan; Tianjiao Xia; Xiaoping Gu展开收起
作者单位
1. Department of Anesthesiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, 210008, People’s Republic of China; 2. Medical School, Nanjing University, Nanjing, Jiangsu, 210093, People’s Republic of China; 3. Nursing School, Jining Medical University, Jining, Shandong, 272067, People’s Republic of China; 4. Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, Jiangsu, 210093, People’s Republic of China; 5. State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, 210093, People’s Republic of China展开收起
官方全文证据 DOI 网页
38 天

Efficacy and Safety of Clobazam as Adjunctive Therapy for Pediatric Patients with Refractory Epilepsy in Xinjiang, China: A Multicenter Real-World Study

作者
Ting Zhao; Hong-Jian Li; Hui-Lan Zhang; Lu-Hai Yu; Jing Yu; Yan Sun; Lu-Feng Cheng展开收起
作者单位
1. Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2. Department of Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi, Xinjiang, People’s Republic of China; 3. Department of Pharmacy, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People’s Republic of China; 4. Department of Precision Medicine, Institute of Clinical Pharmacy of Xinjiang Uygur Autonomous Region, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People’s Republic of China; 5. Department of Neurology, Xinjiang Hospital of Beijing Children’s Hospital, Children’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, People’s Republic of China; 6. Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 7. Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。